A detailed history of Axa S.A. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Axa S.A. holds 193,337 shares of VRTX stock, worth $97.1 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
193,337
Previous 229,891 15.9%
Holding current value
$97.1 Million
Previous $96.1 Million 5.7%
% of portfolio
0.27%
Previous 0.29%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$392.81 - $485.53 $14.4 Million - $17.7 Million
-36,554 Reduced 15.9%
193,337 $90.6 Million
Q1 2024

May 15, 2024

SELL
$407.69 - $446.08 $17.7 Million - $19.4 Million
-43,470 Reduced 15.9%
229,891 $96.1 Million
Q4 2023

Jul 16, 2024

BUY
$343.0 - $410.68 $14.9 Million - $17.9 Million
43,470 Added 18.91%
273,361 $111 Million
Q4 2023

Feb 14, 2024

SELL
$343.0 - $410.68 $4.22 Million - $5.06 Million
-12,314 Reduced 4.31%
273,361 $111 Million
Q3 2023

Nov 14, 2023

BUY
$338.18 - $362.46 $3.49 Million - $3.74 Million
10,329 Added 3.75%
285,675 $99.3 Million
Q2 2023

Aug 14, 2023

SELL
$314.42 - $351.91 $8.99 Million - $10.1 Million
-28,607 Reduced 9.41%
275,346 $96.9 Million
Q1 2023

May 15, 2023

SELL
$283.23 - $323.1 $11.3 Million - $12.8 Million
-39,737 Reduced 11.56%
303,953 $95.8 Million
Q4 2022

Feb 14, 2023

BUY
$285.76 - $321.48 $18.9 Million - $21.3 Million
66,193 Added 23.85%
343,690 $99.3 Million
Q3 2022

Feb 14, 2023

BUY
$273.83 - $305.53 $11.9 Million - $13.3 Million
43,581 Added 18.63%
277,497 $80.3 Million
Q3 2022

Nov 14, 2022

BUY
$273.83 - $305.53 $11.9 Million - $13.3 Million
43,581 Added 18.63%
277,497 $80.3 Million
Q2 2022

Feb 14, 2023

SELL
$234.96 - $292.55 $17.3 Million - $21.6 Million
-73,703 Reduced 23.96%
233,916 $65.9 Million
Q2 2022

Aug 15, 2022

SELL
$234.96 - $292.55 $17.3 Million - $21.6 Million
-73,703 Reduced 23.96%
233,916 $65.9 Million
Q1 2022

Feb 14, 2023

BUY
$221.42 - $260.97 $6.67 Million - $7.86 Million
30,122 Added 10.85%
307,619 $80.3 Million
Q1 2022

May 13, 2022

SELL
$221.42 - $260.97 $21.8 Million - $25.7 Million
-98,580 Reduced 24.27%
307,619 $80.3 Million
Q4 2021

Feb 14, 2022

SELL
$177.01 - $223.45 $2.78 Million - $3.51 Million
-15,690 Reduced 3.72%
406,199 $89.2 Million
Q3 2021

Nov 15, 2021

BUY
$181.39 - $202.99 $36.1 Million - $40.4 Million
198,955 Added 89.24%
421,889 $76.5 Million
Q2 2021

Aug 13, 2021

SELL
$187.49 - $221.1 $2.22 Million - $2.61 Million
-11,825 Reduced 5.04%
222,934 $45 Million
Q1 2021

May 14, 2021

SELL
$207.02 - $241.31 $15.4 Million - $17.9 Million
-74,326 Reduced 24.05%
234,759 $50.4 Million
Q4 2020

Feb 12, 2021

SELL
$207.01 - $276.09 $6.39 Million - $8.53 Million
-30,879 Reduced 9.08%
309,085 $73 Million
Q3 2020

Nov 13, 2020

SELL
$255.65 - $303.1 $33.6 Million - $39.8 Million
-131,440 Reduced 27.88%
339,964 $92.5 Million
Q2 2020

Aug 14, 2020

BUY
$225.48 - $295.8 $10.5 Million - $13.8 Million
46,653 Added 10.98%
471,404 $137 Million
Q1 2020

May 15, 2020

BUY
$199.77 - $247.81 $5.12 Million - $6.36 Million
25,645 Added 6.43%
424,751 $101 Million
Q4 2019

Feb 18, 2020

BUY
$166.71 - $223.91 $18 Million - $24.2 Million
108,147 Added 37.17%
399,106 $87.4 Million
Q3 2019

Nov 14, 2019

SELL
$166.23 - $187.09 $28.2 Million - $31.7 Million
-169,430 Reduced 36.8%
290,959 $49.3 Million
Q2 2019

Aug 13, 2019

SELL
$164.61 - $190.37 $12.7 Million - $14.7 Million
-76,979 Reduced 14.33%
460,389 $84.4 Million
Q1 2019

May 14, 2019

SELL
$163.73 - $194.7 $2.5 Million - $2.98 Million
-15,291 Reduced 2.77%
537,368 $98.8 Million
Q4 2018

Feb 13, 2019

BUY
$151.91 - $192.21 $3.05 Million - $3.86 Million
20,083 Added 3.77%
552,659 $91.6 Million
Q3 2018

Nov 08, 2018

SELL
$167.73 - $192.74 $45.5 Million - $52.3 Million
-271,505 Reduced 33.77%
532,576 $103 Million
Q2 2018

Aug 13, 2018

BUY
$145.72 - $169.96 $16.8 Million - $19.5 Million
114,996 Added 16.69%
804,081 $137 Million
Q1 2018

May 14, 2018

BUY
$151.6 - $177.13 $64.7 Million - $75.6 Million
426,971 Added 162.9%
689,085 $112 Million
Q4 2017

Feb 13, 2018

SELL
$137.28 - $155.55 $1.66 Million - $1.88 Million
-12,084 Reduced 4.41%
262,114 $39.3 Million
Q3 2017

Nov 13, 2017

BUY
$148.13 - $162.24 $40.6 Million - $44.5 Million
274,198
274,198 $41.7 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Axa S.A. Portfolio

Follow Axa S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.